Note 1 - Description of Business (Details Textual)		3 Months Ended		9 Months Ended
	Jun. 24, 2021 shares	Sep. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)	Dec. 30, 2020 USD ($)
Number of Subsidiaries				2
Cash and Cash Equivalents, at Carrying Value, Ending Balance		$ 9,216,349		$ 9,216,349		$ 593,869
Retained Earnings (Accumulated Deficit), Ending Balance		(52,256,361)		(52,256,361)		$ (27,762,963)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total		$ (12,733,250)	$ (5,678,841)	$ (24,625,038)	$ (7,863,870)
ImQuest [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares) | shares	3,282,089
BioLab 612 [Member]
Number of Wholly Owned Subsidiaries				1
GPI [Member]
Equity Method Investment, Ownership Percentage		50.00%		50.00%